Liver International

Cover image for Liver International

December 2003

Volume 23, Issue 6

Pages 405–491

  1. Review Article

    1. Top of page
    2. Review Article
    3. Editorial
    4. Clinical Studies
    5. Basic Studies
    1. You have free access to this content
  2. Editorial

    1. Top of page
    2. Review Article
    3. Editorial
    4. Clinical Studies
    5. Basic Studies
    1. Efficacy of hepatitis C treatment may be enhanced by a longer interferon administration (pages 410–412)

      Edna Strauss and Hoel Sette Junior

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00878.x

  3. Clinical Studies

    1. Top of page
    2. Review Article
    3. Editorial
    4. Clinical Studies
    5. Basic Studies
    1. Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study (pages 413–419)

      G. Tarantino, P. Sorrentino, P. Conca, A. Perrella, P. Ragucci and O. Perrella

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00871.x

    2. Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C (pages 420–425)

      Matthias J. Bahr, Mohamed El Menuawy, Klaus H. W. Boeker, Petra B. Musholt, Michael P. Manns and Ralf Lichtinghagen

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00873.x

    3. Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin (pages 426–433)

      Sheng-Shun Yang, Ming-Yang Lai, Ding-Shinn Chen, Gran-Hum Chen and Jia-Horng Kao

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00875.x

    4. Hepatic dysfunction in patients with extrahepatic portal venous obstruction (pages 434–439)

      M. Rangari, R. Gupta, M. Jain, V. Malhotra and S.K. Sarin

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00879.x

    5. Coagulation disorders in patients with cirrhosis and severe sepsis (pages 440–448)

      Aurélie Plessier, Marie-Hélène Denninger, Yann Consigny, Fabienne Pessione, Claire Francoz, François Durand, Sven Francque, Annie Bezeaud, Laurence Chauvelot-Moachon, Didier Lebrec, Dominique-Charles Valla and Richard Moreau

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00870.x

  4. Basic Studies

    1. Top of page
    2. Review Article
    3. Editorial
    4. Clinical Studies
    5. Basic Studies
    1. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice (pages 449–459)

      Yoshiyuki Ueno, Gianfranco Alpini, Kaichiro Yahagi, Noriatsu Kanno, Yuki Moritoki, Koji Fukushima, Shannon Glaser, Gene LeSage and Tooru Shimosegawa

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00876.x

    2. 15-deoxy-Δ12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-γ, induces apoptosis in human hepatoma cells (pages 460–466)

      Masataka Date, Kazuhide Fukuchi, Shosuke Morita, Hiroshi Takahashi and Kiyoshi Ohura

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00877.x

    3. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells (pages 467–475)

      Hiroaki Yokomori, Masaya Oda, Kazunori Yoshimura, Toshihiro Nagai, Mariko Ogi, Masahiko Nomura and Hiromasa Ishii

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00880.x

    4. Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis (pages 476–483)

      Marcia R. Nagaoka, Maria Kouyoumdjian and Durval R. Borges

      Version of Record online: 27 NOV 2003 | DOI: 10.1111/j.1478-3231.2003.00872.x

SEARCH

SEARCH BY CITATION